Skip to main content
. 2019 Sep 5;30(2):950–960. doi: 10.1007/s00330-019-06399-y

Table 3.

Tumor-based therapy success rates compared with control group

Rate Hepatic dome gr. Control gr. p value
Technical success, n (%) 238/238 (100) 587/587 (100) N/A
Primary technical efficacy, n (%) 232/238 (97.5) 568/587 (96.8) 0.608
Secondary technical efficacy, n (%) 237/238 (99.6) 577/587 (98.3) 0.150
Local recurrence, n (%) 21/238 (8.8) 42/587 (7.2) 0.414

gr. group